Emergency umbilical vein access for newborn resuscitation
Part of Heart & circulation clinical trials.
This trial tests a way to give emergency medication through the umbilical cord (the tube that connects mother and baby) in newborns who need immediate resuscitation. It aims to see if this method works better than other ways of giving medication during a crisis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby must be full-term (born at 37 weeks or later).
- Baby must need emergency resuscitation at birth due to cardiac arrest (no heartbeat) or very slow heart rate (below 60 beats per minute).
- The medical team must have already decided to attempt resuscitation.
- Baby must not have known heart defects or other life-threatening conditions.
- Baby must not already have another IV or access line in place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using ultrasound to guide IV placement helps children who are known to have hard-to-find veins. It aims to make the process quicker and less painful.
This study looks at a specific way to support a newborn’s breathing right after birth when they have congenital diaphragmatic hernia (a birth condition affecting the diaphragm). If you qualify, the team will compare their resuscitation approach to standard care to see if it helps babies in the delivery room.
This trial tests a handheld device called AccuVein that uses a light to help nurses see your veins better, making it easier to start an IV. If you often have trouble getting IVs, this study could help make the process less painful.
This trial looks at whether using heart-monitoring (ECG) can help guide placement of an umbilical vessel catheter (a special line placed through the belly button) in newborns. It may help make line placement safer and more accurate.
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.
Hear when a new Newborn Morbidity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.